Sippican Capital Advisors lessened its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 6.9% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,836 shares of the company’s stock after selling 285 shares during the period. Eli Lilly and Company accounts […]